Literature DB >> 24716790

Potential new clinical therapies for Chagas disease.

Juan M Bustamante1, Rick L Tarleton.   

Abstract

Chagas disease is the highest impact parasitic disease in the Americas but often goes untreated due to the shortcomings of currently available therapeutics. Thus there is an urgent need for new treatment options and growing interest in drug development for the infection. This review summarizes some of the recent advances and failures in this realm, with particular emphasis on recently published studies and unpublished results presented at a recent Chagas Drug Discovery Consortium meeting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24716790     DOI: 10.1586/17512433.2014.909282

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  11 in total

1.  Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases.

Authors:  Renata Tupinambá Branquinho; Carlos Geraldo Campos de Mello; Maykon Tavares Oliveira; Levi Eduardo Soares Reis; Paula Mello de Abreu Vieira; Dênia Antunes Saúde-Guimarães; Vanessa Carla Furtado Mosqueira; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease.

Authors:  Maiara Voltarelli Providello; Zumira Aparecida Carneiro; Gisele Bulhões Portapilla; Gabriel Tavares do Vale; Ricardo Souza Camargo; Carlos Renato Tirapelli; Sérgio de Albuquerque
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

4.  Chagas Disease: A Solvable Problem, Ignored.

Authors:  Rick L Tarleton
Journal:  Trends Mol Med       Date:  2016-08-11       Impact factor: 11.951

Review 5.  Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries.

Authors:  Qin Liu; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2015-12-28       Impact factor: 4.520

6.  Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.

Authors:  Manu De Rycker; John Thomas; Jennifer Riley; Stephen J Brough; Tim J Miles; David W Gray
Journal:  PLoS Negl Trop Dis       Date:  2016-04-15

7.  Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide.

Authors:  Renata Tupinambá Branquinho; Jérôme Roy; Charlotte Farah; Giani Martins Garcia; Franck Aimond; Jean-Yves Le Guennec; Dênia Antunes Saude-Guimarães; Andrea Grabe-Guimaraes; Vanessa Carla Furtado Mosqueira; Marta de Lana; Sylvain Richard
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

8.  Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).

Authors:  Érika Marcela Moreno; Sandra Milena Leal; Elena E Stashenko; Liliana Torcoroma García
Journal:  BMC Complement Altern Med       Date:  2018-07-27       Impact factor: 3.659

9.  Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain.

Authors:  Kátia da Silva Fonseca; Luísa Perin; Nívia Carolina Nogueira de Paiva; Beatriz Cristiane da Silva; Thays Helena Chaves Duarte; Flávia de Souza Marques; Guilherme de Paula Costa; Israel Molina; Rodrigo Correa-Oliveira; Paula Melo de Abreu Vieira; Cláudia Martins Carneiro
Journal:  Pathogens       Date:  2021-06-09

10.  Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling.

Authors:  Alfredo Juárez-Saldivar; Michael Schroeder; Sebastian Salentin; V Joachim Haupt; Emma Saavedra; Citlali Vázquez; Francisco Reyes-Espinosa; Verónica Herrera-Mayorga; Juan Carlos Villalobos-Rocha; Carlos A García-Pérez; Nuria E Campillo; Gildardo Rivera
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.